Moderna Stock Rises 6%, Outperforming Other Vaccine Companies

Moderna's stock saw a 6% increase today, prompting questions about its performance relative to other major vaccine manufacturers like Pfizer and Novavax. The surge indicates investor interest in the company's market position.